Predictive Genetic Testing & Consumer/Wellness Genomics Market Worth $4.6 Billion by 2025: Grand View Research, Inc.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

Rising encouragement for the use of these products is anticipated to propel industrial growth. Expansion in the range of consumer genetic tests by market entities is anticipated to fuel progress in the market in the coming years. Introduction of novel platforms anticipates the DNA-powered applications thus rising market penetration.

Browse full research report with TOC on "Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics), And Trend Analysis From 2013 To 2025" at: http://www.grandviewresearch.com/industry-analysis/predictive-genetic-testing-consumer-wellness-genomics-market

Moreover, the pharmaceutical companies are also engaged in partnerships with genomics companies in order to develop novel therapeutics on the basis of genotypic and phenotypic correlations. For instance, in April 2016 a ten-year deal was signed between Human Longevity Inc. (HLI) and AstraZeneca, in which HLI is supposed to sequence 500,000 genomes of the clinical trial population of AstraZeneca. This data is to be used for the identification of novel drug targets. The deal also provides AstraZeneca with access to the proprietary knowledgebase in order augment biomarker discovery, and facilitate drug development.

Further key findings from the report suggest 

• Application of genetic susceptibility tests in gynecology and endocrinology, is of great interest thereby resulting to higher adoption.
• These tests enable the identification of the susceptibility of genes towards postmenopausal osteoporosis, adenomyosis, and endometriosis.
• Breast & ovarian cancer based predictive testing accounted for the largest share owing to the rising use of susceptibility testing for BRCA mutations cancer prediction.
• Government and pertinent organizations are engaged in endeavors aimed at curbing cancer-related healthcare expenditure by encouraging patients to undergo regular diagnostic examinations.
• CRC screening initiatives undertaken by the governments and implementation of mass CRC screening programs is expected to increase the demand for CRC screening tests.
• Asia Pacific is anticipated to witness substantial growth in the coming years owing to accelerated uptake of these predictive tests in the developing economies of this region.
• Key players contributing in this market are BGI, Illumina, Inc, Pathway Genomics, Genesis Genetics, 23andMe, Inc, ARUP Laboratories, Color Genomics Inc., and Myriad Genetics, Inc.
• These entities are involved in collaborations in order to develop their portfolio with respect to fragmented point-solutions across the genomics value chain.

Browse related reports by Grand View Research: 

• Non-Invasive Prenatal Testing (NIPT) Market - http://www.grandviewresearch.com/industry-analysis/noninvasive-prenatal-testing-market
• Cancer Diagnostics Market - http://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market
• Blood Screening Market - http://www.grandviewresearch.com/industry-analysis/blood-screening-market
• Molecular Diagnostics Market - http://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market

Grand View Research has segmented the predictive genetic testing & consumer/wellness genomics market on the basis of test type, application, and region: 

• Test Type Outlook (Revenue, USD Million, 2013-2025) 
  • Predictive Testing
    • Genetic Susceptibility Test
    • Predictive Diagnostics
    • Population Screening
  • Consumer Genomics
  • Wellness Genomics
• Application Outlook (Revenue, USD Million, 2013-2025) 
  • Predictive Genetic Testing & Consumer Genomics
    • Breast & Ovarian Cancer
    • Cardiovascular screening
    • Diabetic Screening & Monitoring
    • Colon Cancer
    • Parkinsonism / Alzheimer's Disease
    • Urologic screening/ Prostate cancer screening
    • Orthopedic & Musculoskeletal
    • Other cancer screening
    • Other diseases
  • Wellness Genomics
    • Nutria Genetics
    • Skin & Metabolism Genetics
    • Others
• Regional Outlook (Revenue, USD Million, 2013-2025) 
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • Singapore
  • Latin America
    • Brazil
  • Middle East and Africa (MEA)
    • South Africa

Read Our Blog - Exponentially Decreasing Costs for Genetic Sequencing Evolving Trend to Shape Genomic Testing

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: http://www.grandviewresearch.com

SOURCE Grand View Research, Inc.